An estimated one in five pregnant women around the world carry Group B Streptococcus bacteria which is a major, yet preventable, cause of maternal and infant ill health globally
These new offerings join DiaSorin’s menu of more than 60 molecular reagents for bacterial, viral, and fungal targets in addition to human genetic mutations
Findings of recent study may have implications for more effectively treating astronauts with bacterial infections in space, among other potential applications